selected publications
-
Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight.
Nature communications.
2024
Academic Article
GET IT
Times cited: 19 - Mapping genotypes to chromatin accessibility profiles in single cells. Nature. 2024 Academic Article GET IT
- GoT-Splice protocol for multi-omics profiling of gene expression, cell-surface proteins, mutational status, and RNA splicing in human cells. STAR protocols. 2024 Academic Article GET IT
- Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia. Annals of hematology. 2024 Letter GET IT
- Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal. 2024 Academic Article GET IT
- Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization. 2023 GET IT
- Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths. Cell stem cell. 2023 Academic Article GET IT
- Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia. Blood advances. 2022 Academic Article GET IT
- Microenvironment and drug resistance in acute myeloid leukemia: do we know enough?. International journal of cancer. 2021 Review GET IT
-
Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens.
British journal of haematology.
2020
Academic Article
GET IT
Times cited: 18 -
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
Cancer medicine.
2020
Academic Article
GET IT
Times cited: 16 -
Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells.
Molecular cancer research : MCR.
2020
Academic Article
GET IT
Times cited: 12 -
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.
Cell death & disease.
2019
Academic Article
GET IT
Times cited: 32 -
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population.
Haemophilia : the official journal of the World Federation of Hemophilia.
2018
Academic Article
GET IT
Times cited: 2 -
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Frontiers in immunology.
2018
Academic Article
GET IT
Times cited: 15 -
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
Leukemia.
2016
Academic Article
GET IT
Times cited: 29 -
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
PloS one.
2015
Academic Article
GET IT
Times cited: 40 -
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy.
Blood.
2012
Academic Article
GET IT
Times cited: 36